Robert Luxenhofer
Robert Luxenhofer
Professor for Soft Matter Chemistry, Department of Chemistry, University of Helsinki
Verified email at helsinki.fi - Homepage
Title
Cited by
Cited by
Year
Poly (2‐oxazoline) s as Polymer Therapeutics
R Luxenhofer, Y Han, A Schulz, J Tong, Z He, AV Kabanov, R Jordan
Macromolecular rapid communications 33 (19), 1613-1631, 2012
3492012
Overcoming the PEG-addiction: well-defined alternatives to PEG, from structure–property relationships to better defined therapeutics
M Barz, R Luxenhofer, R Zentel, MJ Vicent
Polymer Chemistry 2 (9), 1900-1918, 2011
3132011
Doubly amphiphilic poly (2-oxazoline) s as high-capacity delivery systems for hydrophobic drugs
R Luxenhofer, A Schulz, C Roques, S Li, TK Bronich, EV Batrakova, ...
Biomaterials 31 (18), 4972-4979, 2010
2482010
Synthesis, biodistribution and excretion of radiolabeled poly (2-alkyl-2-oxazoline) s
FC Gaertner, R Luxenhofer, B Blechert, R Jordan, M Essler
Journal of Controlled Release 119 (3), 291-300, 2007
2322007
On the biodegradability of polyethylene glycol, polypeptoids and poly (2-oxazoline) s
J Ulbricht, R Jordan, R Luxenhofer
Biomaterials 35 (17), 4848-4861, 2014
2002014
Click chemistry with poly (2-oxazoline) s
R Luxenhofer, R Jordan
Macromolecules 39 (10), 3509-3516, 2006
1942006
Structure-property relationship in cytotoxicity and cell uptake of poly (2-oxazoline) amphiphiles
R Luxenhofer, G Sahay, A Schulz, D Alakhova, TK Bronich, R Jordan, ...
Journal of Controlled Release 153 (1), 73-82, 2011
1562011
Tailored Poly (2‐oxazoline) Polymer Brushes to Control Protein Adsorption and Cell Adhesion
N Zhang, T Pompe, I Amin, R Luxenhofer, C Werner, R Jordan
Macromolecular bioscience 12 (7), 926-936, 2012
1452012
Peptoids and polypeptoids at the frontier of supra-and macromolecular engineering
N Gangloff, J Ulbricht, T Lorson, H Schlaad, R Luxenhofer
Chemical Reviews 116 (4), 1753-1802, 2016
1412016
Polypeptoids from N-Substituted Glycine N-Carboxyanhydrides: Hydrophilic, Hydrophobic, and Amphiphilic Polymers with Poisson Distribution
C Fetsch, A Grossmann, L Holz, JF Nawroth, R Luxenhofer
Macromolecules 44 (17), 6746-6758, 2011
1272011
Cylindrical molecular brushes of poly (2-oxazoline) s from 2-isopropenyl-2-oxazoline
N Zhang, S Huber, A Schulz, R Luxenhofer, R Jordan
Macromolecules 42 (6), 2215-2221, 2009
1212009
From defined reactive diblock copolymers to functional HPMA-based self-assembled nanoaggregates
M Barz, M Tarantola, K Fischer, M Schmidt, R Luxenhofer, A Janshoff, ...
Biomacromolecules 9 (11), 3114-3118, 2008
1172008
Poly (2-oxazoline) s based biomaterials: A comprehensive and critical update
T Lorson, MM Lübtow, E Wegener, MS Haider, S Borova, D Nahm, ...
Biomaterials 178, 204-280, 2018
1052018
Synergistic combinations of multiple chemotherapeutic agents in high capacity poly (2-oxazoline) micelles
Y Han, Z He, A Schulz, TK Bronich, R Jordan, R Luxenhofer, AV Kabanov
Molecular pharmaceutics 9 (8), 2302-2313, 2012
1032012
Polypeptoids: A perfect match for molecular definition and macromolecular engineering?
R Luxenhofer, C Fetsch, A Grossmann
Journal of Polymer Science Part A: Polymer Chemistry 51 (13), 2731-2752, 2013
1012013
Drug-induced morphology switch in drug delivery systems based on poly (2-oxazoline) s
A Schulz, S Jaksch, R Schubel, E Wegener, Z Di, Y Han, A Meister, ...
ACS nano 8 (3), 2686-2696, 2014
952014
Neuronal uptake and intracellular superoxide scavenging of a fullerene (C60)-poly (2-oxazoline) s nanoformulation
J Tong, MC Zimmerman, S Li, X Yi, R Luxenhofer, R Jordan, AV Kabanov
Biomaterials 32 (14), 3654-3665, 2011
952011
The uptake of N-(2-hydroxypropyl)-methacrylamide based homo, random and block copolymers by human multi-drug resistant breast adenocarcinoma cells
M Barz, R Luxenhofer, R Zentel, AV Kabanov
Biomaterials 30 (29), 5682-5690, 2009
952009
First Aldehyde‐Functionalized Poly (2‐oxazoline) s for Chemoselective Ligation
C Taubmann, R Luxenhofer, S Cesana, R Jordan
Macromolecular bioscience 5 (7), 603-612, 2005
942005
A high capacity polymeric micelle of paclitaxel: Implication of high dose drug therapy to safety and in vivo anti-cancer activity
Z He, X Wan, A Schulz, H Bludau, MA Dobrovolskaia, ST Stern, ...
Biomaterials 101, 296-309, 2016
882016
The system can't perform the operation now. Try again later.
Articles 1–20